Objective: Metformin hydrochloride and sitagliptin are the oral anti-hyperglycemic medications used to treat type 2 diabetes and are used in combination to treat patients. In this work, we have developed a bioanalytical method for simultaneous estimation of both the drugs form some formulation and subsequently the validation of the developed method metformin and sitagliptin in human plasma. Methods: The stability studies were done as per USFDA and EMA guidelines. The sample extraction approach presented here was a straightforward liquid extraction. The linearity range of metformin was 11.72 ng/ml to 3000 ng/ml, and sitagliptin was 4.68 ng/ml. to 1200 ng/ml. For metformin, the LOD was 1.0 ng/ml, and LLOQ was 11.72 ng/ml. and for sitagliptin, the LOD was 0.75 ng/ml, and LLOQ was 4.68 ng/ml. LC-ESI-MS/MS was used to develop and validate this method using the Phenomenex Kinetex C18 column. Milli-Q water containing 10 mmol Ammonium Acetate (pH =3.6) and Acetonitrile containing 0.1% Formic Acid (pH =2.4) as solvent systems for the estimation of Sitagliptin in a single dose. Metoprolol is used as an Internal Standard. Results: The total chromatographic run time was only 7.0 min, and the elute time of metformin and sitagliptin was 3.94 min and 3.97 min, respectively. Relative Bioavailability was found at 101.14% for Metformin and 96.96% for Sitagliptin. The overall results show that the Cmax, AUC0-t, and AUC0-∞ for metformin and sitagliptin were within the acceptable limit of 80%-125%. Conclusion: This bioanalytical method was successfully applied in the bioequivalence study. The study design was a randomized, open-label, two treatment, two-period, two sequences, single-dose, crossover bioequivalence study under fasting conditions.
Since the ancient times herbal formulations have been used in the ailment of various diseases. The plant Ziziphus oenoplia is also known for its various pharmacological activities including wound healing property. But evaluation of the safety of the herbal formulations after application is necessary for their acceptance in the scientific community. As a result, in the current research work sub-chronic dermal toxicity of Ziziphus oenoplia extract incorporated herbal hydrogel was conducted to evaluate its safety profile upon application on the skin. Three different doses of extract loaded hydrogel (1g/kg, 2g/kg and 4g/kg body weight of animals), blank (4g/kg body weight) and control (0.9% NaCl solution) was applied on 15 adult healthy New Zealand White Rabbits in groups of 3 animals each. Application was done on the dorso-ventricular trunk of the rabbits and the animals were observed for 28 days for any clinical signs of intoxication, food consumption and change in body weight gain. After completion of the experiment no skin irritation such as erythema, edema or eschar formation was observed in all the animal groups. No signs of mortality or morbidity was seen. Food consumption was found to be normal and no drastic increase in body weight gain of the rabbits was observed in the control, blank and test groups of rabbits. From this study it was concluded that the Ziziphus oenoplia extract loaded Carbopol hydrogel was non-toxic and could be safely used as a dermal formulation.
9 November 2026 in Revista Brasileira de Farmacognosia